BDBM368217 (2R,5S)-2-methyl-5-[1-(1- methylethyl)-1H-pyrazol-4-yl]-1- {[4-(2H-1,2,3-triazol-2-yl)thiophen- 3-yl]carbonyl}piperidine::US10227336, Example 14

SMILES CC(C)n1cc(cn1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1cscc1-n1nccn1

InChI Key InChIKey=QTUCYHFWJOWQIN-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 368217   

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM368217((2R,5S)-2-methyl-5-[1-(1- methylethyl)-1H-pyrazol-...)
Affinity DataIC50: 430nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM368217((2R,5S)-2-methyl-5-[1-(1- methylethyl)-1H-pyrazol-...)
Affinity DataIC50: 1.00E+4nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent